Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Topical finasteride may help treat hair loss in men and women.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Chewing betel nut may increase the risk of type 2 diabetes, and saw palmetto can improve urinary symptoms in BPH with fewer side effects but may cause bleeding and allergic reactions.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

A woman was allergic to quinine in her anti-hair loss lotion.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

The document suggests "Occupational Skin Disease" is a useful standard text, finds "The Clinical Management of Itching" poorly organized, recommends "Atlas of Contact Dermatitis" for its illustrations, and values "Handbook of Diseases of the Hair and Scalp" for its information despite flaws.

The document explains how shampoos clean, rinses condition, one-step shampoos offer convenience, and hair growth promoters aim to prevent hair loss, emphasizing the importance of scientific evidence for their effectiveness.

Several health and medical conferences are planned for 1991.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

The reply suggests checking for false positive or asymptomatic syphilis and using penicillin for treatment if necessary.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

DHT may increase the risk of heart disease and death in elderly men.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.